• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    92 Biggest Movers From Friday

    5/9/22 6:27:28 AM ET
    $ACOR
    $ACRX
    $AERI
    $AMLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACOR alert in real time by email

    Gainers

    • Sidus Space, Inc. (NASDAQ:SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the commercialization of space technologies and services.
    • The Arena Group Holdings, Inc. (NYSE:AREN) gained 43.5% to close at $15.00. Arena Group recently posted a Q1 loss of $1.20 per share.
    • Nuvectis Pharma, Inc. (NASDAQ:NVCT) jumped 30.2% to close at $18.20.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) shares surged 28% to settle at $3.29. Vinco Ventures set record date as May 18, 2022 For dividend of shares related to Cryptyde deal. The dividend is expected to be distributed on May 27, 2022.
    • Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) gained 27.3% to close at $4.10. Tabula Rasa HealthCare recently posted Q1 sales of $83.60 million.
    • Funko, Inc. (NASDAQ:FNKO) rose 26.9% to settle at $21.22 after The Chernin Group announced a consortium led by TCG will make a $263M strategic investment in Funko at $21 per share. Funko also reported upbeat quarterly results.
    • Swvl Holdings Corp. (NASDAQ:SWVL) gained 23.9% to close at $7.47 on Friday. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company.
    • Mesa Royalty Trust (NYSE:MTR) surged 21.6% to settle at $15.85 amid a gain in oil prices.
    • Forge Global Holdings, Inc. (NYSE:FRGE) rose 20.7% to close at $32.58.
    • Global Cord Blood Corporation (NYSE:CO) gained 19.6% to close at $2.63. Global Cord Blood recently reported the purchase of Cellenkos for $11 per share, for a total value of $664 million.
    • DMC Global Inc. (NASDAQ:BOOM) jumped 19.3% to close at $25.41 following strong Q1 results.
    • Radius Global Infrastructure, Inc. (NASDAQ:RADI) gained 17.7% to close at $14.71.
    • Radius Global was reportedly said to mull options including a sale.
    • Sky Harbour Group Corporation (NASDAQ:SKYH) jumped 17.2% to settle at $7.31.
    • BellRing Brands, Inc. (NASDAQ:BRBR) gained 17.1% to close at $24.42 after the company reported better-than-expected Q2 EPS and sales results.
    • Humanigen, Inc. (NASDAQ:HGEN) jumped 16.9% to settle at $2.15. Humanigen posted a Q1 loss of $0.32 a share.
    • AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) gained 16.9% to close at $0.2450.
    • Udemy, Inc. (NASDAQ:UDMY) jumped 16.7% to close at $12.54 after the company reported better-than-expected Q1 EPS and sales results.
    • Cazoo Group Ltd (NYSE:CZOO) surged 15.8% to close at $1.32.
    • Grid Dynamics Holdings, Inc. (NASDAQ:GDYN) gained 15.6% to close at $17.39 following Q1 results.
    • Sequans Communications S.A. (NYSE:SQNS) jumped 15.2% to close at $3.11.
    • Sequans Communications recently posted Q1 adjusted loss of $0.04 per share.
    • Stem, Inc. (NYSE:STEM) rose 15.1% to close at $8.79 after the company reported better-than-expected Q1 sales results and reaffirmed FY22 guidance.
    • Canaan Inc. (NASDAQ:CAN) gained 14.9% to settle at $4.10.
    • Unum Group (NYSE:UNM) gained 13.8% to close at $36.31 following upbeat quarterly earnings.
    • Cypress Environmental Partners, L.P. (NYSE:CELP) rose 13.% to close at $0.4883.
    • Jounce Therapeutics, Inc. (NASDAQ:JNCE) gained 13% to close at $5.49 after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $15 to $20.
    • Turtle Beach Corporation (NASDAQ:HEAR) gained 12.2% to close at $16.62. Turtle Beach weighed a sales process as it considers ways to maximize value for shareholders.
    • Athersys, Inc. (NASDAQ:ATHX) rose 12.2% to settle at $0.6251 following a narrower-than-expected quarterly loss.
    • ChemoCentryx, Inc. (NASDAQ:CCXI) gained 11.1% to close at $17.38 following Q1 results.
    • Cooper-Standard Holdings Inc. (NYSE:CPS) gained 9.7% to close at $6.25 after the company reported better-than-expected Q1 sales results.
    • Adtalem Global Education Inc. (NYSE:ATGE) shares jumped 9.4% to close at $30.87 after the company reported upbeat Q3 results.
    • PepGen Inc. (NASDAQ:PEPG) gained 7.4% to close at $12.89 as the company priced its IPO at $12 per share.
    • Stagwell Inc. (NASDAQ:STGW) gained 7.1% to close at $6.84 after reporting Q1 results.
    • RxSight, Inc. (NASDAQ:RXST) rose 7% to close at $11.35 after the company reported better-than-expected Q1 EPS results.
    • iRhythm Technologies, Inc. (NASDAQ:IRTC) rose 5.8% to close at $124.97 after the company reported better-than-expected Q1 sales results and issued FY22 revenue guidance above analyst estimates.
    • AvidXchange Holdings, Inc. (NASDAQ:AVDX) gained 5.3% to close at $8.14 after the company reported better-than-expected Q1 EPS and sales results and raised FY22 sales guidance above analyst estimates.

     

    Losers

    • Digital Brands Group, Inc.. (NASDAQ:DBGI) shares dipped 54.7% to close at $0.2250 on Friday after the company priced its 37.39 million share offering at $0.25 per share.
    • The Joint Corp. (NASDAQ:JYNT) shares fell 37.9% to close at $17.41 after the company reported downbeat Q1 results.
    • Clovis Oncology, Inc. (NASDAQ:CLVS) dropped 32.6% to close at $0.9914 after HC Wainwright downgraded the stock form Buy to Neutral.
    • Endo International plc (NASDAQ:ENDP) fell 29.7% to close at $1.42 after the company reported Q1 earnings results and issued Q2 guidance.
    • Meten Holding Group Ltd. (NASDAQ:METX) declined 28.2% to close at $1.95 following effectiveness of 1-for-30 reverse stock split.
    • Palisade Bio, Inc. (NASDAQ:PALI) fell 27.6% to close at $0.5143 after the company announced a $2 million registered direct offering.
    • Under Armour, Inc. (NYSE:UAA) dropped 23.8% to close at $10.89 after the company reported Q1 adjusted EPS results were down year over year and issued FY23 adjusted EPS guidance below estimates.
    • Guardant Health, Inc. (NASDAQ:GH) fell 22.5% to close at $39.32. Guardant Health's Q1 FY22 revenues rose 22% Y/Y to $96.1 million.
    • SAI.TECH Global Corporation (NASDAQ:SAI) dipped 22.1% to close at $5.25.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) dropped 21.4% to close at $0.3030 after the company reported worse-than-expected Q1 EPS results.
    • fuboTV Inc. (NYSE:FUBO) fell 21.1% to close at $3.25 after the company reported Q1 earnings results.
    • Bill.com Holdings, Inc. (NYSE:BILL) declined 20.5% to close at $121.00 after the company reported Q3 earnings results and issued Q4 guidance.
    • Austin Gold Corp. (NYSE:AUST) dropped 20.4% to close at $2.96. Austin Gold recently priced its 3.265 million share IPO at $4 per share.
    • Bloom Energy Corporation (NYSE:BE) shares fell 20.2% to close at $15.13 after the company reported downbeat quarterly results.
    • Zai Lab Limited (NASDAQ:ZLAB) dropped 20.2% to close at $28.55.
    • Remitly Global, Inc. (NASDAQ:RELY) declined 20.1% to close at $8.30 following Q1 results.
    • Bandwidth Inc. (NASDAQ:BAND) dropped 19.9% to close at $21.41. Needham downgraded Bandwidth from Buy to Hold.
    • ShiftPixy, Inc. (NASDAQ:PIXY) fell 19.7% to close at $0.2570.
    • Better Therapeutics, Inc. (NASDAQ:BTTX) fell 19.7% to close at $1.88. The company is expected to release quarterly results on May 13, 2022.
    • Century Therapeutics, Inc. (NASDAQ:IPSC) declined 19.6% to settle at $8.57.
    • Backblaze, Inc. (NASDAQ:BLZE) dropped 19.3% to close at $7.79 after the company reported Q1 earnings results and issued Q2 and FY22 sales guidance.
    • IT Tech Packaging, Inc. (NYSE:ITP) fell 19.2% to close at $0.4038.
    • DISH Network Corporation (NASDAQ:DISH) fell 19.1% to close at $22.22 after the company reported Q1 EPS and sales results down from last year.
    • Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) declined 19% to close at $6.25 following Q1 results.
    • Axsome Therapeutics, Inc. (NASDAQ:AXSM) fell 18.8% to settle at $29.82. The U.S. Food and Drug Administration recently issued a Complete Response Letter (CRL) to Axsome Therapeutics regarding its New Drug Application (NDA) for AXS-07 for the acute treatment of migraine.
    • CareDx, Inc (NASDAQ:CDNA) dropped 18.6% to close at $25.78 after the company reported worse-than-expected Q1 EPS results.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) declined 18.6% to close at $0.9683.
    • Vapotherm, Inc. (NYSE:VAPO) fell 18.5% to settle at $3.65. Canaccord Genuity downgraded Vapotherm from Buy to Hold and lowered the price target from $12 to $5.
    • GoPro, Inc. (NASDAQ:GPRO) declined 18.3% to close at $7.15 after the company reported worse-than-expected Q1 sales results.
    • Compass Minerals International, Inc. (NYSE:CMP) fell 18.3% to close at $48.11 following Q1 results.
    • Calyxt, Inc. (NASDAQ:CLXT) dipped 18% to settle at $0.3150 after the company reported Q1 earnings results.
    • Ranpak Holdings Corp. (NASDAQ:PACK) fell 17.6% to close at $12.36 after the company reported worse-than-expected Q1 sales results.
    • Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) dropped 17.6% to close at $7.65.
    • PLAYSTUDIOS, Inc. (NASDAQ:MYPS) dipped 17.3% to close at $4.77. PLAYSTUDIOS posted a Q1 loss of $0.20 per share.
    • Burning Rock Biotech Limited (NASDAQ:BNR) fell 17.2% to close at $4.25.
    • Sana Biotechnology, Inc. (NASDAQ:SANA) declined 16.7% to close at $6.38.
    • Chembio Diagnostics, Inc. (NASDAQ:CEMI) dropped 16.3% to settle at $0.5580. Chembio Diagnostics posted a Q1 loss of $0.29 per share.
    • PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) declined 16% to close at $12.76.
    • Confluent, Inc. (NASDAQ:CFLT) dropped 16% to close at $23.73 after the company reported Q1 earnings results.
    • HashiCorp, Inc. (NASDAQ:HCP) fell 15.8% to close at $39.00.
    • Cloudflare, Inc. (NYSE:NET) fell 15.7% to close at $65.61 after the company reported Q1 earnings results and issued Q2 guidance.
    • Ubiquiti Inc (NYSE:UI) dropped 15.6% to close at $232.79 following Q3 results.
    • Qurate Retail, Inc. (NASDAQ:QRTEA) dropped 15.3% to close at $8.30 after the company reported worse-than-expected Q1 EPS and sales results.
    • Pulmonx Corporation (NASDAQ:LUNG) fell 15.3% to close at $19.16. Pulmonx posted a Q1 loss of $0.43 per share.
    • Alpha and Omega Semiconductor Limited (NASDAQ:AOSL) dropped 14.7% to close at $38.54 after the company reported Q3 earnings results and issued Q4 sales guidance.
    • Illumina, Inc. (NASDAQ:ILMN) fell 14.6% to close at $249.05 after the company reported Q1 financial results.
    • News Corporation (NASDAQ:NWS) fell 13.7% to close at $16.91 after the company reported Q3 financial results.
    • Clean Energy Fuels Corp. (NASDAQ:CLNE) fell 13.6% to close at $5.13 after the company reported worse-than-expected Q1 EPS and sales results.
    • Entravision Communications Corporation (NYSE:EVC) declined 13.6% to close at $4.44 after the company reported worse-than-expected Q1 EPS results.
    • Zhihu Inc. (NYSE:ZH) shares fell 12.6% to close at $1.52.
    • Gain Therapeutics, Inc. (NASDAQ:GANX) fell 11.4% to close at $3.43. Gain Therapeutics presented preclinical data from its GBA Parkinson's Disease program. The results were highlighted in a poster presentation at the XXVII World Congress on Parkinson's Disease and Related Disorders.
    • Farmer Bros. Co. (NASDAQ:FARM) dropped 10.6% to close at $5.89 following Q3 results.
    • Primerica, Inc. (NYSE:PRI) declined 10.6% to close at $115.93 following downbeat quarterly results.
    • U.S. Xpress Enterprises, Inc. (NYSE:USX) fell 10.5% to close at $3.08 after the company reported worse-than-expected Q1 sales results.
    • Teradata Corporation (NYSE:TDC) fell 10.2% to close at $35.84 after the company issued weak earnings forecast.
    • bluebird bio, Inc. (NASDAQ:BLUE) dropped 8.1% to close at $3.73.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) fell 7.5% to close at $1.74.
    Get the next $ACOR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACOR
    $ACRX
    $AERI
    $AMLX

    CompanyDatePrice TargetRatingAnalyst
    Palisade Bio Inc.
    $PALI
    2/25/2026$5.00Buy
    Stifel
    Century Therapeutics Inc.
    $IPSC
    2/25/2026Buy
    TD Cowen
    Backblaze Inc.
    $BLZE
    2/24/2026$4.50Buy → Hold
    Craig Hallum
    Bloom Energy Corporation
    $BE
    2/24/2026$162.00Neutral
    Citigroup
    Axsome Therapeutics Inc.
    $AXSM
    2/24/2026$230.00Outperform
    Wolfe Research
    Guardant Health Inc.
    $GH
    2/20/2026$125.00 → $135.00Buy
    Canaccord Genuity
    Guardant Health Inc.
    $GH
    2/17/2026$120.00Outperform
    Robert W. Baird
    Cloudflare Inc.
    $NET
    2/13/2026$215.00Hold → Buy
    DZ Bank
    More analyst ratings

    $ACOR
    $ACRX
    $AERI
    $AMLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Pinkus Gary S sold $207,250 worth of shares (1,250 units at $165.80), decreasing direct ownership by 23% to 4,149 units (SEC Form 4)

    4 - Bloom Energy Corp (0001664703) (Issuer)

    2/27/26 7:55:55 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    Chief Operations Officer Chitoori Satish was granted 15,409 shares, increasing direct ownership by 7% to 245,426 units (SEC Form 4)

    4 - Bloom Energy Corp (0001664703) (Issuer)

    2/27/26 7:47:05 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    Chief Commercial Officer Joshi Aman was granted 19,393 shares and sold $1,756,000 worth of shares (10,000 units at $175.60), increasing direct ownership by 5% to 210,465 units (SEC Form 4)

    4 - Bloom Energy Corp (0001664703) (Issuer)

    2/27/26 7:33:41 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    $ACOR
    $ACRX
    $AERI
    $AMLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced that on February 23, 2026, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock units ("RSUs") representing 41,852 shares of its common stock to 88 new non-executive employees and one non-qualified stock option award to purchase 4,965 shares of its common stock to one new non-executive employee with a grant date of February 23, 2026 under the Guardant Health, Inc. 2023 Employment Inducement Incentive Award Plan (the "Inducement Plan"). The RSUs and stock options were granted as inducements material to the employees entering into employment with Guardant i

    2/27/26 4:05:00 PM ET
    $GH
    Medical Specialities
    Health Care

    CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    CareDx, Inc. (NASDAQ:CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the award of inducement grants. On February 24, 2026, as an inducement material to acceptance of employment with CareDx, 35 new employees were awarded restricted stock units (RSUs) for an aggregate of 82,137 shares of common stock. The RSU awards were made pursuant to the Company's 2016 and 2025 Inducement Equity Incentive Plans in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, wit

    2/27/26 4:01:00 PM ET
    $CDNA
    Medical Specialities
    Health Care

    Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida

    Increased adoption of clinical whole-genome sequencing is advancing diagnostics for rare diseases, which affect 15 million American childrenSAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that Illumina Laboratory Services, Illumina's CLIA-certified laboratory, is providing clinical sequencing and interpretation services to the new Diagnostic Lab at Florida Institute for Pediatric Rare Diseases (IPRD) at Florida State University (FSU) College of Medicine, further driving innovation in diagnostics and treatments for rare diseases. "An estimate

    2/27/26 9:15:00 AM ET
    $ILMN
    Medical Specialities
    Health Care

    $ACOR
    $ACRX
    $AERI
    $AMLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel initiated coverage on Palisade Bio with a new price target

    Stifel initiated coverage of Palisade Bio with a rating of Buy and set a new price target of $5.00

    2/25/26 7:53:12 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    TD Cowen initiated coverage on Century Therapeutics

    TD Cowen initiated coverage of Century Therapeutics with a rating of Buy

    2/25/26 7:49:49 AM ET
    $IPSC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Backblaze downgraded by Craig Hallum with a new price target

    Craig Hallum downgraded Backblaze from Buy to Hold and set a new price target of $4.50

    2/24/26 8:01:18 AM ET
    $BLZE
    Computer Software: Prepackaged Software
    Technology

    $ACOR
    $ACRX
    $AERI
    $AMLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Jobson Charles E bought $130,874 worth of Common (15,397 units at $8.50), increasing direct ownership by 0.94% to 1,645,294 units (SEC Form 4)

    4 - JOINT Corp (0001612630) (Issuer)

    2/17/26 5:36:26 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    Large owner Jobson Charles E bought $3,898 worth of Common (448 units at $8.70), increasing direct ownership by 0.03% to 1,639,597 units (SEC Form 4)

    4 - JOINT Corp (0001612630) (Issuer)

    2/13/26 5:16:01 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    Director Gottlieb Scott bought $23,562 worth of shares (200 units at $117.81), increasing direct ownership by 2% to 12,723 units (SEC Form 4)

    4 - ILLUMINA, INC. (0001110803) (Issuer)

    2/11/26 4:04:54 PM ET
    $ILMN
    Medical Specialities
    Health Care

    $ACOR
    $ACRX
    $AERI
    $AMLX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    July 30, 2024 - FDA Roundup: July 30, 2024

    For Immediate Release: July 30, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA is announcing the fiscal year (FY) 2025 user fee rates for importers approved to participate in the Voluntary Qualified Importer Program (VQIP) and accreditation and certification bodies interested in participating in the Accredited Third-Party C

    7/30/24 3:38:18 PM ET
    $GH
    Medical Specialities
    Health Care

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $ACRX
    $AERI
    $AMLX
    SEC Filings

    View All

    SEC Form 144 filed by Bandwidth Inc.

    144 - Bandwidth Inc. (0001514416) (Subject)

    2/27/26 6:14:12 PM ET
    $BAND
    Computer Software: Prepackaged Software
    Technology

    SEC Form SD filed by Alpha and Omega Semiconductor Limited

    SD - ALPHA & OMEGA SEMICONDUCTOR Ltd (0001387467) (Filer)

    2/27/26 4:24:20 PM ET
    $AOSL
    Semiconductors
    Technology

    Grid Dynamics Holdings Inc. filed SEC Form 8-K: Financial Statements and Exhibits

    8-K - GRID DYNAMICS HOLDINGS, INC. (0001743725) (Filer)

    2/27/26 4:15:43 PM ET
    $GDYN
    Computer Software: Prepackaged Software
    Technology

    $ACOR
    $ACRX
    $AERI
    $AMLX
    Leadership Updates

    Live Leadership Updates

    View All

    CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer

    Kennedy brings seven years of public company CFO experience CareDx, Inc. (NASDAQ:CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced that Keith Kennedy, the Company's Chief Operating Officer (COO), will also assume the responsibilities of Chief Financial Officer (CFO) and oversee the Company's finance organization effective February 26, 2026. Kennedy brings to CareDx over 20 years of experience and executive leadership in healthcare including global diagnostics, biopharma services, and contrac

    2/24/26 5:15:00 PM ET
    $CDNA
    Medical Specialities
    Health Care

    Backblaze Appoints Rhett Dillingham Senior Vice President of Product

    Backblaze adds strategic AI and cybersecurity leader to drive innovation and operational excellence to continue scaling its platform for the AI era Backblaze, Inc. (NASDAQ:BLZE), the high-performance cloud storage platform for the AI era, today announced the appointment of Rhett Dillingham as Senior Vice President of Product, strengthening the company's executive leadership team as its cloud storage platform and AI use cases continue to scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224045978/en/Rhett Dillingham, Senior Vice President of Product at Backblaze Dillingham brings more than two decades of product manageme

    2/24/26 4:01:00 PM ET
    $BLZE
    Computer Software: Prepackaged Software
    Technology

    Remitly Appoints Sebastian J. Gunningham as Chief Executive Officer

    SEATTLE, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly" or the "Company") today announced the appointment of Sebastian J. Gunningham as Chief Executive Officer ("CEO") and member of the Board of Directors (the "Board"), effective February 19, 2026. Mr. Gunningham succeeds Co-Founder Matt Oppenheimer, who decided to transition the role of CEO to a new leader after nearly 15 years of driving transformative growth that built Remitly into one of the world's leading networks for digital and physical money movement. Mr. Oppenheimer will continue to serve as Chairman of the Board. Sebastian Gunningham brings decades of global leadership and product innovation exp

    2/18/26 4:05:00 PM ET
    $RELY
    Real Estate

    $ACOR
    $ACRX
    $AERI
    $AMLX
    Financials

    Live finance-specific insights

    View All

    Ranpak to Hold Conference Call to Discuss Fourth Quarter 2025 Results

    Ranpak Holdings Corp. (NYSE:PACK) announced today that it will release its fourth quarter results at approximately 7:30 a.m. (ET) on Thursday, March 5, 2026 and will host a conference call and webcast at 8:30 a.m. (ET) on that day. The conference call and earnings presentation will be webcast live at the following link: https://events.q4inc.com/attendee/881128699. Investors who cannot access the webcast may listen to the conference call live via telephone by dialing (800) 715-9871 and use the Conference ID: 8666426. A telephonic replay of the webcast also will be available starting at 11:30 a.m. (ET) on Thursday, March 5, 2026 and ending at 11:59 p.m. (ET) on Thursday, March 12, 2026. T

    2/26/26 7:30:00 AM ET
    $PACK
    Containers/Packaging
    Consumer Discretionary

    The Joint Corp. to Report 2025 Fourth Quarter and Full Year Results on Thursday, March 12 and Host Conference Call and Webcast

    SCOTTSDALE, Ariz., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT) the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, announced it will report its 2025 fourth quarter and full year financial results on Thursday, March 12, 2026, after the market close and host a conference call and simultaneous webcast at 5:00 p.m. ET that day. During the call, The Joint Corp. President and CEO Sanjiv Razdan and CFO Scott Bowman will review the Company's financial results and provide a business update, followed by a question-and-answer session. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing

    2/26/26 7:05:00 AM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates

    – Total revenues grew 17% y-o-y to $127.6 million for the fourth quarter of 2025 and 15% y-o-y to $460.2 million for the full-year 2025 – Zocilurtatug pelitecan (zoci) on track to become Zai Lab's first global oncology launch, with three registration-enabling studies across 2L+ SCLC, 1L SCLC, and extrapulmonary NECs by the end of 2026 – Advancing a differentiated global pipeline, including ZL-1503 (IL-13/IL-31Rα), ZL-6201 (LRRC15 ADC), ZL-1222 (PD-1/IL-12) and ZL-1311 (MUC17/CD3 TCE) – Key regional programs continue to advance, with KarXT approved in China and commercial launch preparations underway; pivotal data readouts for povetacicept in IgAN and elegrobart in TED expected in 2026

    2/26/26 7:00:00 AM ET
    $ZLAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $ACRX
    $AERI
    $AMLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PMV Pharmaceuticals Inc.

    SC 13G - PMV Pharmaceuticals, Inc. (0001699382) (Subject)

    12/12/24 12:29:41 PM ET
    $PMVP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Illumina Inc.

    SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

    12/6/24 10:11:24 AM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Illumina Inc.

    SC 13G - ILLUMINA, INC. (0001110803) (Subject)

    12/5/24 7:27:01 PM ET
    $ILMN
    Medical Specialities
    Health Care